MedTrace Logo

COPD Readmissions Prediction- ReCOPD Project

NCT03227211 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1500

Last updated 2022-01-13

No results posted yet for this study

Summary

To develop predictive models for short-term readmission (60 days) and medium term (one year) for patients with an exacerbation of COPD (eCOPD) which are admitted to any of the participant hospitals. To identify factors contributing to readmission from the time of discharge from the index admission to the studied readmission time. Methodology. Design: Prospective cohort study with a nested case control study, with follow up to one year. Patients: 1500 patients admitted over a year and a half in any of the 9 participant hospitals by an eCOPD. Methods: During admission, background information on patient situation prior to admission, data of the ED during admission, and discharge planning, will be collected from medical history. The investigators will also survey patients (generic and specific health-related quality life -HRQoL- dependence, social support, presence of fragility). All patients will be followed to determining whether any readmission until 60 and up to one year of discharge from the index admission occurs. Patients readmitted at the first 60 days after discharge will be surveyed on a number of possible causes of readmission (continuity of care, medication, complications, individual and social factors). A one to one control group will be established to compare different factors studied in the case group (readmission). Statistical analysis: predictive models will be developed from the derivation sample, and validated in a validation sample. Also, the factors evaluated in the case-control study will be compared using appropriate test for paired samples.

Conditions

  • Pulmonary Disease, Chronic Obstructive, Severe Early-Onset

Sponsors & Collaborators

  • Hospital de Basurto

    collaborator OTHER

  • Hospital Santa Marina

    collaborator UNKNOWN

  • Hospital de Cruces

    collaborator OTHER

  • Hospital Donostia

    collaborator OTHER

  • Hospital Universitario Araba

    collaborator OTHER

  • Hospital General Universitario Gregorio Marañon

    collaborator OTHER

  • Hospital Univeritario Ntra. Sra. de la Candelaria

    collaborator UNKNOWN

  • Hospital Costa del Sol

    collaborator OTHER

  • Hospital Galdakao-Usansolo

    lead OTHER_GOV

Principal Investigators

  • Jose M Quintana, MD, PhD · Chief of Research Unit

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-10-01
Primary Completion
2020-06-30
Completion
2020-06-30

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03227211 on ClinicalTrials.gov